0.5mg X 30 tabs
Cabergoline 0.5 mg (Cabercare)
Cabergoline is a dopamine D2 receptor agonist classified as a pharmaceutical-grade compound, studied for its effects on prolactin regulation and dopaminergic signalling pathways. Each pack contains 30 tablets of 0.5 mg, manufactured by Careclub Pharmaceuticals to USP standards.
It is primarily investigated in research settings focused on prolactin modulation and endocrine system interactions, particularly involving dopamine-mediated hormonal control.
Research applications include:
Prolactin regulation — studied for suppression of prolactin secretion via D2 receptor activation
Dopaminergic activity — examined for effects on dopamine receptor signalling pathways
Pharmacokinetics — characterised by a long half-life supporting infrequent dosing in research models
Endocrine research — used in studies involving hormonal balance and pituitary regulation mechanisms
Receptor affinity — noted for strong selective binding to D2 receptors
